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SUMMARY.  
Aims: This paper aims to describe current trends in the UK primary care management of common 
mental disorders and explore the appropriateness of differing management approaches in light of the 
course and common complications of these disorders.  
Methods: It highlights key findings concerning the course and comorbidity of depression to indicate 
that depression and associated mental illnesses may often form part of more complex patterns of ill 
health and that these conditions have a clear potential for chronicity. A narrative review of studies 
providing detail of depression prevalence in selected comorbid conditions is presented for this 
purpose.  
Conclusion: The presentation and course of common mental disorders indicate organizational 
changes in health service delivery, and - for a sizeable patient group – the use of chronic disease 
management strategies. 
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Common mental disorders are a major public health problem, causing high levels of disability and 
interacting in a deleterious way with other conditions; current and proposed developments in the UK 
highlight differing management approaches.  
 
Depression and related common mental disorders have high prevalence, and are a major source of 
disability throughout the world (Paykel, 2006). Depression currently accounts for more disability than 
any other mental illness, and more than diabetes, hypertension, or chronic lung disease (Panzarino, 
Jr., 1998). An extensive literature enables evaluation of the evidence for a range of management 
strategies encompassing case finding methods, medicines and talking treatments, and broader 
organisational approaches. Increasingly, reviews of these interventions are prepared to provide 
guidelines for individual patient management and ongoing service development. The public health 
importance of these conditions has appropriately generated a wealth of such research and policy 
initiatives in the UK (NICE, 2004a, b; Goldberg, 2006), USA (Office of the Surgeon General, 1999), 
the European Union (European Commission Health & Consumer Protection Directorate-General, 
2005) and elsewhere (World Health Organisation, 2001). 
 
Recent developments in the UK represent two different approaches to the public health challenge of 
managing common mental health problems. Prompted by steadily accumulating evidence of 
treatment efficacy together with a re-evaluation of the economic costs of these disorders, a proposed 
innovation involves a national plan to develop accessible therapy centres in Britain. It appears clear 
that psychological (most notably cognitive behavioural) treatments are not only effective, but also 
accord with most patients’ treatment preferences. The current proposal identifies a large-scale 
shortage of suitably trained therapists, and proposes a major expansion of the therapist workforce, 
involving the additional training of 10,000 new psychological therapists. Further, the proposals reason 
that the work of therapists should be organised in a way that closely mirrors the typical team and 
work-base structures of the therapy teams from which evidence of effect has been derived. Hence, 
the development of some 250 psychological therapy centres in the UK has been mooted (Layard, 
2004; 2006).  
 
At the same time as plans for a grand expansion of capacity for individual psychotherapy have been 
developed, a very different approach to community health management has been implemented. The 
negotiation of a new service agreement, the General Medical Services (GMS) contract in April 2004, 
has been a major organisational development in primary care in England, of which the the Quality and 
Outcomes Framework (QOF) is an important part. The QOF identifies a number of indicators of 
practice organisation and disease management, and rewards practices according to their 
achievements on these clinical indicators and measures of quality of care (Ashworth & Armstrong, 
2006; Payne & Steadman, 2005). 
 
The QOF system has identified severe mental illness (largely synonymous with psychotic illnesses) 
and depression (alongside conditions such as diabetes, epilepsy, cancer, and coronary heart disease 
[CHD]) as conditions which are likely to benefit from this systematic management approach. Points 
are awarded for organising and maintaining a practice database of patients with these conditions, 
ensuring appropriate case measures are used, and offering regular monitoring. Importantly, links 
between conditions are addressed by depression case finding tools being routinely used for patients 
on the CHD and diabetes registers. 
 
These are two very different approaches to the management of common mental disorders, and their 
relevant merits relate to considerations of feasibility and effectiveness. Fundamentally, their 
appropriateness relates to the nature of depression and common psychological conditions in our 
communities. The following discussion will examine the nature of common mental disorders, with 
special consideration of issues of illness duration, comorbidity, and treatment response. 
 
COMMON MENTAL DISORDER – POTENTIAL FOR CHRONICITY 
Depression and associated common mental disorders are increasingly viewed as chronic illnesses, 
involving sustained impairment and high rates of symptom recurrence in a large proportion of 
patients. At least half of those people who develop a depressive episode will experience further 
episodes (Judd et al., 1998), and between- 10% and 30% of depressed patients experience a chronic 
course characterised by significant functional impairment (Kennedy et al., 2004). For many people 
with depression there is a fluctuating presentation involving subsyndromal, minor depressive and 
major depressive symptoms. A similar pattern of chronicity is evident for anxiety disorders (Kessler et 
al., 2001). 
 
A model of care suited to chronic diseases has been effectively used for medical conditions such as 
hypertension, diabetes, and asthma, and evidence from well-conducted primary care based studies 
indicates that this approach is effective for depression (Rost et al., 2002; Dietrich et al., 2004). It 
appears that the principles of this management approach - explicit evidence-based guidelines, patient 
education for self-management, stepped care involvement of specialist resources, links with 
community resources - together with the organisational changes required to embed these approaches 
within services (information systems such as patient registers, reminders, progress indicators; and 
new staff roles and ways of working such as primary care nurse case managers, and tele-support) are 
a central part of effective interventions strategies (Von Korff & Goldberg, 2001). 
 
Not only is the course of depression and anxiety unlikely to be clear-cut and acute for many patients, 
but also, for a considerable proportion of people, these conditions are one of a number of overlapping 
health problems. This comorbidity or ‘multiple morbidity’ is characteristic of primary care work, and is 
set to be more evident within our ageing populations. 
 
COMORBIDITY 
Study of the co-occurrence of common mental disorders and medical illness has most frequently 
focused on depression and cardiovascular disease, stroke, diabetes, chronic pain, and hypertension. 
These studies have shown that, before constructing any aetiological model, it is important to consider 
confounding explanations of an association. The most important confounding factor is an artefact of 
depression measurement due to overlap between symptoms of the medical condition and those 
considered features of depression. The Geriatric Depression Scale (GDS) (Yesavage et al., 1982) 
and the Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983) are two widely 
used measures developed to counter this problem.  
 
The relation between depression and medical disorders such as cancer, heart disease, Parkinson’s 
disease, Alzheimer’s disease, stroke, and arthritis has been categorised as one of epidemiological 
comorbidity and clinical comorbidity. That is, there is a changed likelihood of depression caseness 
associated with these conditions, and there is a changed course, treatment response, and prognosis 
associated with the coexistence of the conditions (Krishnan et al., 2002). 
 
This association has serious consequences, the most compelling being the increased risk of mortality 
it confers. Pooled data from community studies of older (>65) people with a mood disorder have 
identified an elevated all-cause mortality rate of 1.75 times (Geerlings et al., 2002). The effect of 
depression on mortality appears to be modified by gender, with additional excess mortality risk 
conferred by male gender (Abas et al., 2002). This may be because men have more cardiovascular 
pathology, the course of which is strongly affected by depression, as well as because of increased 
likelihood of suicide among men (Schoevers et al., 2000). 
 
Much of this body of research has explored the relationship between depression and cardiac disease: 
epidemiological investigation some 80 years ago identified a grossly elevated mortality ratio among 
institutionalised patients with ‘involution melancholia’, and that ‘diseases of the heart constitute the 
leading cause of death’ (Malzberg, 1937). A series of increasingly sophisticated studies have 
developed understanding of this association (Glassman & Shapiro, 1998), revealing that the relative 
risk of subsequent cardiac mortality is three-fold increased in cardiac patients with major depression, 
(compared with non-depressed cardiac patients) after adjusting for confounding factors. A similar 
level of excess cardiac mortality has been identified between depressed and comparison subjects 
without cardiac disease at baseline (Penninx et al., 2001). Although greatest risk is associated with 
moderate and severe depression, it appears that even minimal levels of depression symptoms are 
associated with increased mortality after myocardial infarction (Bush et al., 2001). Additionally, a 
number of prospective studies have shown that depressed individuals without prior coronary heart 
disease (CHD) are more likely to develop CHD in the ensuing years than comparable, non-depressed 
persons (Ahern et al., 1990).  
 
Other serious conditions appear to be associated with mental illness: there is an increased 
prevalence of depression among cancer patients, with rate linked to pain, level of physical disability, 
and severity of illness. Much of this association appears to be a reaction to and manifestation of the 
disease and its treatment (Krishnan et al., 2002). However, one longitudinal study of community 
samples of older people (>70 years) has also indicated a temporal link between chronic depression 
and an increased risk of cancer incidence after controlling for a range of confounders (age, sex, race, 
smoking, alcohol, disability, hospital admissions) (Penninx et al., 1998). Another study has indicated 
more rapid cancer progression in subjects with severe depression, psychopathology appearing an 
important predictor of survival time after controlling for other risk factors (Brown et al., 2003). 
 
The relationship between physical illness and mental disorders appears to be complex, with a range 
of potential causal pathways and interactions between factors. Mental disorders may exacerbate pre-
existing physical illnesses or contribute to their onset. For example, the presence of depression in 
individuals free of coronary artery disease confers an approximately 1.5-fold to 2.0- fold adjusted 
relative risk for the subsequent development of this disease, and evidence from longitudinal studies in 
the U.S. and Japan indicates that depression doubles the risk of incident type 2 diabetes, 
independent of its association with other risk factors (Anderson et al., 2001). Furthermore, in patients 
with pre-existing diabetes, depression is an independent risk factor for coronary heart disease, and 
appears to accelerate the presentation of coronary heart disease. 
 
This relation might operate by means of the poor health behaviours which may accompany many 
mental illnesses, for instance, smoking is twice as common among people with current mental 
disorders in the US (Lasser et al., 2000). Additionally, mental disorders may influence physical health 
via direct physiological effects (such as immune dysfunction, decreased heart rate variability, 
alterations in platelet receptors and blood clotting, decreased bone mineral density, low body mass 
index caused by poor appetite, as well as ventricular instability and myocardial ischaemia in reaction 
to mental stress, sympathoadrenal hyperactivity, and elevated insulin and cholesterol levels), which 
play a part in the incompletely understood disease pathways such as those linking depression to the 
onset of myocardial infarctions, strokes and osteoporosis, and to the development of diabetes 
(Haddad, 2004). 
 
The treatment of mental illness can also affect physical health, via the various adverse effects of 
medications, such as antidepressants and increased falls among older adults, benzodiazepines and 
excess risk of road traffic incidents, or the association between the antipsychotic drugs clozapine and 
olanzapine and insulin resistance and weight gain. Conversely, physical illness appears to be an 
important risk factor for the development of mental illnesses: patients with disabilities related to 
various medical illnesses have an increased risk of depression and anxiety disorders (Lenze et al., 
2001), as have older persons with vascular disease; and a wide range of commonly prescribed 
medications may precipitate mood disorders (House & Stark, 2002). 
 
Studies have reported high levels of comorbidity between psychological disorders and medical 
conditions such as Parkinson’s disease, stroke, chronic respiratory disease, diabetes, multiple 
sclerosis, and cardiac disease. Individuals not infrequently suffer from several such conditions: Lai et 
al. (2002) identified a third of their sample of 459 stroke patients (mean age of 70) to have diabetes, 
and nearly one-fifth (19%) to have myocardial infarction. In these populations, depression contributes 
significantly to disability, increased carer burden, more rapid cognitive decline (Parkinson’s disease), 
more bodily pain, prolonged length of hospital stays, and increased risk of mortality.  
 
The reduced capability for physical functioning, limitations in activities of daily living, and loss of 
traditional social roles that may accompany these medical conditions confer an independent risk for 
the onset and maintenance of common mental disorders. Additional mechanisms for these 
relationships include cerebrovascular changes (as in heart disease and diabetes), localised disruption 
to frontostriatal brain circuits (as occurs in stroke), neurodegenerative brain changes (Alzheimer’s 
disease, idiopathic Parkinson’s disease), and pain (as in arthritis or cancer).  
 
Table I illustrates the respective prevalence of common mental disorders (mostly depression) among 
people with a number of important comorbid conditions. Studies have been selected primarily on the 
basis of adequacy of sample sizes, clarity concerning population specification, and methodological 
robustness. However it must be noted that there are a number of problems evident in the literature 
concerning mental and physical illness comorbidity. Importantly, many studies purporting to identify 
comorbid disease associations mistakenly correlate ‘lifetime prevalences’ in mixed aged subjects. 
Because the measured disorder rates are non-decreasing functions, correlated lifetime prevalences in 
a sample of subjects with a range of ages almost always reveal a positive correlation, even if the two 
disorders are only randomly associated. This identifies a “pseudo-correlation” that is particularly likely 
to be observed with disorders whose hazard increases with age (Krishnan et al., 2002). This statistical 
artefact is resolved by stratifying prevalence data by age group, but this necessitates sample sizes 
beyond that of most studies.  
 
It must also be noted that the majority of research on the physical illness–psychiatric disorder 
relationship has been based on clinical reports of patients treated in specialty medical settings and 
many clinical studies rely on samples of convenience; with few exceptions, they do not consider 
whether samples are representative or whether the nature or magnitude of the observed disorder 
relationships can be generalized to other populations. 
 
TREATMENT RESPONSE 
Psychotherapy and pharmacotherapy or combinations of these form a key part of the traditional 
management of common mental disorders. There appears little difference in the effects of particular 
treatments, either in terms of drug types, or the active and goal-oriented psychotherapies (cognitive, 
behavioural, or interpersonal) (Robinson et al., 1990), and only limited benefits from combinations of 
either different drugs or of drugs and talking treatments. These approaches appear effective for many 
of those treated, with response rates for depressed patients in the region of 60% and remission rates 
around 10% lower (Casacalenda et al., 2002). But, the findings of repeated studies are that for a 
sizeable proportion of depressed patients, response to treatments is likely to be suboptimal. A 
management approach in which the prime focus is on remission is not appropriate for many people, 
and may be disheartening for those whose symptoms persist despite treatments. 
 
CONCLUSION 
Common mental disorders, like many of the health problems prevalent in industrialised societies, 
require complex management which reflects both therapeutic optimism and the reality - for many 
patients - of the ongoing disabling effects of these disorders. 
 
 
 
Table I: The prevalence of depression associated with selected medical conditions. 
Study/Review Condition/Subjects/ 
sample size 
Prevalence/Measure 
Weintraub et al. 
(2006) 
Parkinson’s Disease  
out-patients n=148 
22% depression (DSM-IV diagnostic interview) 
 
Lai et al. (2002) 
 
Burvill et al. 
(1997) 
 
Robinson (2003) 
Stroke  
out-patients n=459 
 
out-patients 4mnths post-stroke 
n=191 
 
Review 18 in-patient studies 
n=1865 
15 out-patient studies n=1693 
 
4 community studies n=1083 
 
33% depression (GDS-15 ≥6) 
 
28% depression 15% major; 8%minor (DSM-III diagnostic 
interview) 
 
36% depression 19% major; 19%minor (DSM-III & various 
self-report) 
33% depression 23% major; 15% minor (DSM-III & various 
self-report) 
32% depression 14% major; 9% minor (DSM-III & various 
self-report)  
 
Wagena et al. 
(2005) 
 
Yohannes et al. 
(2000) 
 
van Ede et al. 
(1999) 
COPD  
occupational cohort n=4468/4520 
 
out-patients (age 60-89) n=137. 
 
Review 9 studies largely out-
patients, n= 771 
 
14% depression (HADS-D ≥11) 
19% anxiety (HADS-A ≥11) 
 
42% depression (GMS≥3) 
18% anxiety (GMS≥3) 
 
7% (HADS ≥11) -42% (MMPI)  
29% (HADS≥8); 42% (BDI ≥15);  
29% (CES-D ≥19);  
28% (Zung ≥45); 
12% (DSM-III diagnostic interview) 
 
Schleifer et al. 
(1989) 
Rudisch & 
Nemeroff (2003) 
Myocardial Infarction 
hospitalised patients n=283 
 
 
Review 4 studies post-MI n=955 
 
18% major depression (DSM-III diagnostic interview) 
 
15%-27% major depression (RDC or DSM criteria) 
 
Milani & Lavie 
(1998) 
 
Lett et al. (2004) 
 
 
Rudisch & 
Nemeroff (2003) 
Coronary artery disease  
out-patients ≥65 n=268 
 
 
Review 5 studies hospitalised & 
out-patients n=1059 
 
Review 5 studies hospitalised & 
out-patients n=880 
 
18% depression (Symptom Questionnaire >6) 
 
 
14%-23% major depression (DSM-III/-IV diagnostic 
interview) 
 
17%-23% major depression (RDC or DSM criteria) 
 
Anderson et al.  
(2001) 
Type 1 & Type 2 diabetes  
Review 39 studies settings: 
community, clinic, hospital, adults 
and older people n= 20218 
 
11.4% major depression (14 studies: DSM-III/-IV diagnostic 
interview; 
31% depression (25 studies: GDS ≥21, BDI ≥10/13/16, 
CES-D ≥16/17/20/23, Zung ≥50/45, MMPI-D) 
Chwastiak et al. 
(2002) 
Multiple sclerosis  
Community sample n= 739 
 
29.1% depression (CES-D≥21) 
BDI (Beck depression inventory); Zung SDS (Zung self-rating depression scale); HADS (Hospital anxiety and depression 
questionnaire); CES-D (center for epidemiologic studies-depression questionnaire); MMPI (Minnesota multiphasic 
personality inventory); Geriatric Mental State Schedule (GMS) 
 
Much of our evidence for the management of common psychological illness relates to single 
treatments – drugs and psychotherapies. These approaches have increasingly clear evidence bases 
that assist our formulation of individual and population management strategies. However, there is a 
potential that care directed by evidence and protocols concerning single health conditions may be 
inappropriate for and possibly disadvantage people with complex patterns of ill-health (Wright et al., 
2003). It seems a vital part of the management of these conditions involves organisational 
approaches geared to their complexity, chronicity, and disabling impact. Primary care studies have 
shown benefits for patients related to improved working arrangements between primary and 
secondary care and more systematic follow up, often involving case management and telephone 
support. 
 
The recent developments noted in UK health care typify different and apparently valid responses to 
depression and anxiety disorders. Debate pitting organisational against conventional therapeutic 
approaches, or population against individual strategies is bound to involve sterile argument. The care 
of complex health problems must incorporate a range of intervention types, and prioritise robust 
evaluation of effects. However, the value of chronic disease approaches has been well demonstrated 
in the management of other disorders, and this model has been successfully applied to depression. 
Such an approach holds promise as a central aspect of primary care approaches to depression, 
involving the recognition that depression is a life course disorder and providing a systematic 
sequence of interventions within a collaborative care and stepped care model (Tylee, 2006), rather 
than piecemeal management of acute presentations (Scott, 2006). 
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